A $480,000-a-Year Pill Reflects a New Normal for Cancer Drugsnews2026-08-31T16:43:57+00:00August 31st, 2026|The New York Times|
Walmart to Pay $50 Million to Settle Opioid Lawsuit, US Saysnews2026-08-29T01:08:49+00:00August 29th, 2026|The New York Times|
New Drug Approved by F.D.A. for Pancreatic Cancer Could Be First of Manynews2026-08-27T09:02:45+00:00August 27th, 2026|The New York Times|
F.D.A. Approves the Drug Daraxonrasib That’s Poised to Transform Pancreatic Cancernews2026-08-26T16:54:01+00:00August 26th, 2026|The New York Times|
Can We Do Anything About Tick-Borne Diseases Like Alpha-Gal Syndrome?news2026-08-20T15:07:16+00:00August 20th, 2026|The New York Times|
Moderna’s Shift to Cancer Company Lifts Stock Up 177%news2026-08-20T14:23:51+00:00August 20th, 2026|The New York Times|
What Is Treatment-Resistant Depression?news2026-08-20T10:39:38+00:00August 20th, 2026|The New York Times|
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returningnews2026-08-19T15:37:24+00:00August 19th, 2026|The New York Times|
How One Woman With a Very Rare Disease Secured a Clinical Trialnews2026-08-17T09:01:50+00:00August 17th, 2026|The New York Times|